Third annual JBC Methods Madness tournament
Calling all scientists! The Journal of Biological Chemistry’s third annual Methods Madness tournament is finally here.
Last year’s tournament stirred up quite the rivalry, with #TeamMassSpec dethroning #TeamCryo as the #JBCMethodsMadness champion! This year we welcome new contenders, including #TeamFlow, #TeamMedicine and #TeamProtein. Will one of these newbies make it to the finals? You decide!
The madness begins on Monday, March 7. (See tournament schedule below.) Submit your bracket by Sunday, March 6, for a chance to win a $100 gift card.
Round 1: The Scientific 16
Vote for your favorite methods by participating in polls posted by .
Monday, March 7
9 a.m. – #TeamMassSpec vs. #TeamNMR
2 p.m. – #TeamXRC vs. #TeamImmuno
Tuesday, March 8
9 a.m. – #TeamChroma vs. #TeamFRET
2 p.m. – #TeamFlow vs. #TeamPCR
Wednesday, March 9
9 a.m. – #TeamCRISPR vs. #TeamOmics
2 p.m. – #TeamSuperRes vs. #TeamOpto
Thursday, March 10
9 a.m. – #TeamCryo vs. #TeamMedicine
2 p.m. – #TeamLiveCell vs. #TeamProtein
All times Eastern.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
RA patient blood reveals joint innerworkings
Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.
Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥� to help the patients who need it most.
Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥� and just getting started.
Defeating deletions and duplications
Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.
Using 'nature鈥檚 mistakes' as a window into Lafora disease
After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.
Cracking cancer鈥檚 code through functional connections
A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.